+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Platelet Rich Plasma Market by Source Type (Allogenic, Autologous, Homologous), Application (Cosmetic Surgery, General Surgery, Neurosurgery) - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968873
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Platelet Rich Plasma Market grew from USD 381.63 million in 2023 to USD 430.86 million in 2024. It is expected to continue growing at a CAGR of 12.09%, reaching USD 848.54 million by 2030.

PRP is prepared by centrifuging a sample of the patient's blood, resulting in a platelet concentration above baseline values. The therapeutic use of PRP has gained popularity due to its potential to augment the body's innate healing process. PRP can be applied in various medical fields, including orthopedics, dentistry, sports medicine, wound healing, and the burgeoning field of aesthetic medicine. Increasing demand for minimally invasive treatments, a rise in the prevalence of sports injuries and orthopedic conditions, and an aging population seeking cosmetic and anti-aging treatments have proliferated the need for platelet rich plasma products and treatments. However, the need for more high-quality, randomized controlled trials to prove its efficacy for various indications and the high cost of PRP therapy can limit patient access to platelet rich plasma products and treatments. Nevertheless, the ongoing technological innovations to improve PRP treatments' efficacy, safety, and convenience are expected to contribute to adopting PRP treatments. Moreover, collaborative efforts with academic institutions to produce the robust clinical data necessary to validate applications encourage the adoption of PRP treatments in the coming years.

Regional Insights

The platelet rich plasma market in the Americas is rapidly developing owing to a high emphasis on advancing medical procedures and sports medicine, an aging population seeking regenerative treatments for musculoskeletal conditions, and a high concentration of athletes looking for rapid recovery solutions. Customer purchasing behavior in the Americas favors innovative and minimally invasive therapies. The European Union (EU) presents a unified regulatory landscape for PRP therapies, with increasing research activity. The need for PRP treatment is fueled by a robust healthcare infrastructure and customers' preference for high-quality, regulated treatments. The Middle East has a burgeoning market for cosmetic treatments, including PRP therapies, supported by affluent consumers seeking high-end medical services. In contrast, the African PRP market is more nascent, driven primarily by gradually improving healthcare facilities and the increasing accessibility of treatments. Asia-Pacific is rapidly emerging as a significant PRP product market characterized by its large population and developing healthcare sectors. The emerging economies have shown a considerable increase in the adoption of PRP therapies, driven by rising disposable incomes and increasing medical tourism. Across the Asia Pacific, customer purchasing patterns are evolving, shifting towards valuing advanced treatments and a willingness to invest in health and wellness.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Platelet Rich Plasma Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Growing Incidences of Sports-Related Injuries Globally
  • Potential Application in the Treatment of Musculoskeletal Conditions and Orthopedic Disorders
  • Increasing Use in Cosmetic Surgery and for Natural Healing Process

Market Restraints

  • Uncertainty on Therapeutic Efficacy of Platelet Rich Plasma

Market Opportunities

  • Emerging Application in Regenerative Medicine
  • Ongoing Research and Development Activities on Platelet-Rich Plasma Derived Bioactive Molecules

Market Challenges

  • Limited Availability of Clinical Trials and Reimbursement Policies of Platelet-rich Plasma Products

Market Segmentation Analysis

  • Source Type: Preference for Autologous PRP due to its safety profile
  • Application: Extensive use of PRP treatments in orthopedic applications

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Platelet Rich Plasma Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Platelet Rich Plasma Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Hairline International Launches Sonicated PRP- a cutting edge Hair Regeneration Therapy

Hairline International Hair and Skin Clinic introduced an advanced hair regeneration therapy, known as Sonicated PRP, which is poised to transform the approach to hair follicle stimulation and revival. Sonicated PRP leverages the powerful effects of platelet sonicates to awaken dormant hair follicles and promote growth at the cellular level. This next-generation therapy has shown its merit by enriching 16 vital growth factors, predicting a new era in hair restoration more effective than traditional PRP treatments.

Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE PRFM

Royal Biologics unveiled BIOINCYTE PRFM, an innovative technology advancing the realm of Platelet Rich Plasma (PRP) systems. This state-of-the-art solution elevates PRP by transforming it into an ultra-pure Platelet Rich Fibrin Matrix (PRFM), significantly reducing the contamination seen with red and white blood cells.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Platelet Rich Plasma Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Platelet Rich Plasma Market, highlighting leading vendors and their innovative profiles. These include APEX Biologix, Arthrex, Inc., Cascade Medical Wellness & Aesthetics, Celling Biosciences, Inc., Crown Laboratories, Inc., Dr PRP USA LLC, EmCyte Corporation, Estar Technologies Ltd., Exactech, Inc., Factor Medical Inc., Fisher Scientific Company L.L.C., Integrity PRP, Isto Biologics, Johnson & Johnson Services, Inc., Juventix Regenerative Medical, LLC, MDBiologix, PRP Concepts, Inc., Regen Lab SA, ROCKY MOUNTAIN BIOLOGICALS, Sarstedt AG & Co. KG, Stryker Corporation, Terumo BCT, Inc., Terumo Corporation, ThermoGenesis Holdings, Inc., Ycellbio Medical Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Platelet Rich Plasma Market to forecast the revenues and analyze trends in each of the following sub-markets:

Source Type

  • Allogenic
  • Autologous
  • Homologous

Application

  • Cosmetic Surgery
  • General Surgery
  • Neurosurgery
  • Orthopedic Surgery

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Incidences of Sports-Related Injuries Globally
5.1.1.2. Potential Application in the Treatment of Musculoskeletal Conditions and Orthopedic Disorders
5.1.1.3. Increasing Use in Cosmetic Surgery and for Natural Healing Process
5.1.2. Restraints
5.1.2.1. Uncertainty on Therapeutic Efficacy of Platelet Rich Plasma
5.1.3. Opportunities
5.1.3.1. Emerging Application in Regenerative Medicine
5.1.3.2. Ongoing Research and Development Activities on Platelet-Rich Plasma Derived Bioactive Molecules
5.1.4. Challenges
5.1.4.1. Limited Availability of Clinical Trials and Reimbursement Policies of Platelet-rich Plasma Products
5.2. Market Segmentation Analysis
5.2.1. Source Type: Preference for Autologous PRP due to its safety profile
5.2.2. Application: Extensive use of PRP treatments in orthopedic applications
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Platelet Rich Plasma Market, by Source Type
6.1. Introduction
6.2. Allogenic
6.3. Autologous
6.4. Homologous
7. Platelet Rich Plasma Market, by Application
7.1. Introduction
7.2. Cosmetic Surgery
7.3. General Surgery
7.4. Neurosurgery
7.5. Orthopedic Surgery
8. Americas Platelet Rich Plasma Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Platelet Rich Plasma Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Platelet Rich Plasma Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. Hairline International Launches Sonicated PRP- a cutting edge Hair Regeneration Therapy
11.3.2. Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE PRFM
12. Competitive Portfolio
12.1. Key Company Profiles
12.2. Key Product Portfolio
List of Figures
FIGURE 1. PLATELET RICH PLASMA MARKET RESEARCH PROCESS
FIGURE 2. PLATELET RICH PLASMA MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PLATELET RICH PLASMA MARKET DYNAMICS
FIGURE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 20. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PLATELET RICH PLASMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 26. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 31. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 32. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 33. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 36. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 37. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 40. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 41. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 44. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 45. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 46. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 47. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 48. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 49. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 52. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 54. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 58. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 59. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 60. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 61. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 64. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 65. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 68. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 69. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 72. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 73. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 76. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 77. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 80. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 81. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 84. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 85. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 88. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 89. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 92. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 93. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 96. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 97. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 100. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 101. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 104. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 105. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 113. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 114. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 115. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 118. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 119. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 122. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 123. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 126. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 127. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 130. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 131. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 134. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 135. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 138. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 139. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 142. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 143. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 146. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 147. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 150. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 151. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 154. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 155. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 158. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 159. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 162. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 163. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 166. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 170. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 174. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 175. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 178. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 179. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 182. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 183. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 186. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 187. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
TABLE 194. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 198. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • APEX Biologix
  • Arthrex, Inc.
  • Cascade Medical Wellness & Aesthetics
  • Celling Biosciences, Inc.
  • Crown Laboratories, Inc.
  • Dr PRP USA LLC
  • EmCyte Corporation
  • Estar Technologies Ltd.
  • Exactech, Inc.
  • Factor Medical Inc.
  • Fisher Scientific Company L.L.C.
  • Integrity PRP
  • Isto Biologics
  • Johnson & Johnson Services, Inc.
  • Juventix Regenerative Medical, LLC
  • MDBiologix
  • PRP Concepts, Inc.
  • Regen Lab SA
  • ROCKY MOUNTAIN BIOLOGICALS
  • Sarstedt AG & Co. KG
  • Stryker Corporation
  • Terumo BCT, Inc.
  • Terumo Corporation
  • ThermoGenesis Holdings, Inc.
  • Ycellbio Medical Co., Ltd.
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information